Does an EF of 40-45% Mean Heart Failure?
An ejection fraction of 40-45% does NOT automatically mean you have heart failure—it indicates heart failure with mildly reduced ejection fraction (HFmrEF) ONLY if the patient also has current or previous symptoms of heart failure plus objective evidence of elevated cardiac filling pressures. 1
Understanding the Classification
According to the 2022 AHA/ACC/HFSA guidelines, the EF range of 40-45% falls into the HFmrEF category (LVEF 41-49%), which sits between:
Critical Diagnostic Requirements
The diagnosis requires THREE components, not just the EF number:
Classic HF symptoms and signs (dyspnea, fatigue, edema, reduced exercise tolerance)
LVEF of 41-49% on echocardiography
Objective evidence of elevated filling pressures, which can be demonstrated by:
- Elevated natriuretic peptides (BNP/NT-proBNP)
- Echocardiographic diastolic parameters (E/e' ≥15)
- Invasive hemodynamic measurements at rest or with exercise
- Evidence of structural heart disease (increased left atrial volume index or LV mass index) 1
Without symptoms and elevated filling pressures, an EF of 40-45% alone does not constitute a heart failure diagnosis.
Clinical Context Matters
The HFmrEF population represents 10-25% of all heart failure patients and appears to be a dynamic, transitional category 3. In community-based studies, only 12.5% of incident heart failure cases present with HFmrEF, and these patients frequently transition: 26.9% decline to HFrEF (EF ≤40%) and 44.8% improve to HFpEF range (EF ≥50%) on follow-up 4.
Key clinical features of HFmrEF patients:
- More similar to HFpEF than HFrEF in demographics and comorbidity burden
- High prevalence of ischemic heart disease (more similar to HFrEF in this respect)
- Intermediate cardiovascular risk profile
- Mean age typically mid-70s with mixed gender distribution 3, 4
Prognostic Implications
The relationship between EF and cardiovascular outcomes shows that mortality risk increases by 39% for every 10% reduction in EF below 45% 5. However, once EF rises above 45%, further increases do not substantially reduce cardiovascular risk—the risk plateaus 5. This means:
- An EF of 40-45% carries higher risk than EF >45%
- But the absolute risk difference between 45% and 60% is minimal
- The critical threshold appears to be 45%, not the traditional 40% cutoff
Treatment Implications
If heart failure IS diagnosed with EF 40-45%, treat similarly to HFrEF. The guidelines recommend considering HFrEF therapies for HFmrEF patients, including:
Evidence from post-hoc analyses suggests drugs effective in HFrEF may also benefit HFmrEF patients, though dedicated trials are lacking 3, 6.
Common Pitfalls to Avoid
- Don't diagnose heart failure based on EF alone—you must have symptoms plus elevated filling pressures
- Don't assume static EF—repeat measurements are essential as HFmrEF is often transitional
- Don't withhold HFrEF therapies if true HFmrEF is diagnosed—these patients likely benefit from guideline-directed medical therapy
- Don't ignore the trajectory—whether EF is improving from lower values or declining from higher values matters for prognosis and management 1
Special Consideration: HF with Improved EF
If a patient previously had HFrEF (EF <40%) and now has EF 40-45%, they are classified as HFimpEF (heart failure with improved ejection fraction) and should continue all HFrEF treatments indefinitely, as discontinuation often leads to relapse 2, 1, 7.